Oct 16, 2026 08:30AM
Oct 16, 2026 08:29AM
Aug 25, 2026 04:01PM
Aug 25, 2026 04:01PM
Aug 19, 2026 05:29AM
Aug 18, 2026 08:00AM
Aug 13, 2026 07:30AM Ascendis Pharma Reports Second Quarter 2026 Financial Results
Aug 6, 2026 08:01AM
Aug 6, 2026 08:00AM
Jun 30, 2026 08:30AM
Jun 25, 2026 04:01PM
Jun 3, 2026 04:30AM
May 7, 2026 07:30AM
May 6, 2026 04:01PM Ascendis reports sustained growth in achondroplasia trial subgroup
May 6, 2026 04:01PM
Apr 8, 2026 08:02AM
Apr 8, 2026 08:01AM
Apr 6, 2026 04:01PM
Apr 6, 2026 04:01PM
Mar 31, 2026 08:00AM
Mar 19, 2026 08:00AM Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Mar 17, 2026 08:32AM
Mar 17, 2026 08:30AM
Mar 16, 2026 08:00AM
Mar 12, 2026 08:48AM
Mar 2, 2026 03:49PM
Mar 2, 2026 10:38AM
Mar 2, 2026 09:19AM Stifel Reiterates Buy Rating on Ascendis Pharma (ASND) as Yuviwel Approved for Achondroplasia
Mar 2, 2026 04:55AM
Feb 27, 2026 05:57PM
Feb 27, 2026 05:57PM
Feb 23, 2026 05:31PM
Feb 19, 2026 05:31PM
Feb 12, 2026 07:41AM
Feb 11, 2026 04:01PM Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results
Jan 9, 2026 06:01PM
Jan 8, 2026 04:04PM
Jan 8, 2026 04:01PM
Nov 26, 2025 07:00AM
Nov 26, 2025 06:48AM
Nov 25, 2025 06:15PM
Nov 24, 2025 08:53AM TD Cowen Reiterates Buy Rating on Ascendis Pharma (ASND)
Nov 17, 2025 04:10PM
Nov 16, 2025 03:00PM
Nov 13, 2025 06:55AM
Nov 12, 2025 04:01PM
Oct 8, 2025 04:01PM
Oct 8, 2025 04:01PM
Sep 23, 2025 08:59AM UBS Reiterates Buy Rating on Ascendis Pharma (ASND)
Aug 7, 2025 04:01PM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All